Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: 7 May 2026
Pembrolizumab with chemoradiation for untreated high-risk advanced cervical cancer [TSID10690]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC